Search for: "Astrazeneca" Results 961 - 980 of 1,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Oct 2009, 4:00 am
AstraZeneca was formed through a 1999 merger between Britain's Zeneca Group PLC and Sweden's Astra AB, the parent of Astra USA.Corporate boards face mounting pressure to crack down on executives who breach their fiduciary duty, said Thomas C. [read post]
5 Oct 2009, 10:08 pm
London-based AstraZeneca Plc has its U.S. headquarters in Delaware, while Menendez represents Whitehouse Station, New Jersey-based Merck & Co., among other companies.The issue may still come up on the floor because some senators want the industry to contribute more to cut costs and raise revenue. [read post]
28 Sep 2009, 9:56 pm
Sometimes, Sins of Omission Are Not Inequitable Conduct By Kevin E. [read post]
24 Sep 2009, 8:28 pm
"AstraZeneca loses price inflation lawsuit appeal": The Associated Press has this report on a ruling that the U.S. [read post]
23 Sep 2009, 10:40 pm
The judge allowed AstraZeneca to withhold physicians' names on privacy grounds. [read post]
23 Sep 2009, 10:02 pm
AstraZeneca Pharmaceuticals LP, No. 08-1056 (1st Cir. [read post]
23 Sep 2009, 6:31 am
It took two years before AstraZeneca gave their United States patients and doctors the same warning. [read post]
23 Sep 2009, 1:12 am
Many of the suits also claim AstraZeneca promoted Seroquel, approved by the U.S. [read post]
3 Sep 2009, 9:59 pm
Henry Grabowski (professor of economics at Duke University) and Richard Wang (director of health services research and policy analysis at AstraZeneca Pharmaceuticals) and concluded... [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
19 Aug 2009, 5:41 am
(Patent Docs) US: BIO files amicus brief in Bilski (Patent Docs) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) US: European biosimilars market may hint at limited US threat (GenericsWeb) US: Chris Hansen on the Myriad lawsuit (Patents4Life)   Products Effexor (Venlafaxine) – US: Wyeth files suit alleging Alphapharm’s Enlafax infringes its Venlafaxine patent; Generic Health, which recently registered… [read post]
17 Aug 2009, 3:19 am
For example, EADS, whose shares do not trade on the U.S. exchanges, is the target of a U.S. securities lawsuit (about which refer here)   Indeed concerns about these extraterritoriality issues clearly have influenced at least some courts to decline to exercise jurisdiction over the claims of foreign domiciled investors (refer for example here, with regard to the case involving AstraZeneca). [read post]
16 Aug 2009, 9:58 pm
Astrazeneca LP et al. v. [read post]
12 Aug 2009, 8:09 am
(Spicy IP) UK: Hindsight going forward: taking the risk factor into account: Lilly Icos, Pfizer Enterprises, Merck, AstraZeneca & Ors v 8pm Chemists & Ors (IP finance) US: Gene patenting debate continues – round two (Patent Docs) US: Follow-on biologics news briefs – no 7 (Patent Docs) US: BIO urges Supreme Court to reject rigid Bilski rule (PatentBIOtech) US: Cargill withdraws patent infringement case before ITC against Nantong Foreign Medicines… [read post]
5 Aug 2009, 8:52 am
AstraZeneca knows that its early successes in defeating Seroquel lawsuits have given it momentum. [read post]